HIGHLIGHTS
- who: Tao Guan from the Department of Pathology, Harvard Medical School, United States Catholic University of have published the Article: Circulating tumor DNA mutation profile is associated with the prognosis and treatment response of Chinese patients with newly diagnosed diffuse large B-cell lymphoma, in the Journal: (JOURNAL)
- what: Considering that different races can have varied gene mutation profiles and that the clinical value of ctDNA in Chinese patients remains largely unknown, in this study, the authors explored the clinical significance of ctDNA in 169 newly diagnosed Chinese DLBCL patients. The study showed that age . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.